ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Overview Fund Activity
Delisted

ANTH was delisted on the 27th of June, 2018.

Back to rankings

74 hedge funds and large institutions have $70.5M invested in Anthera Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.98%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
7
Increased
31
Reduced
14
Closed
5
Calls
$558K
Puts
$651K
Net Calls
-$93K
Net Calls Change
-$256K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.51M
2
State Street
State Street
Massachusetts
+$731K
3
BCM
Bridgeway Capital Management
Texas
+$463K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$297K
5
WC
Wexford Capital
Florida
+$232K

Top Sellers

1
GCM
Gruss Capital Management
New York
-$2.56M
2
SCM
Sio Capital Management
New York
-$1.61M
3
RPAM
Rhenman & Partners Asset Management
Sweden
-$417K
4
SM
Sabby Management
Florida
-$306K
5
TC
TFS Capital
Pennsylvania
-$301K
Name Holding Trade Value Shares
Change 		Shares
Change %
AQR Capital Management
76
AQR Capital Management
Connecticut
– -$120K -4,136 Closed
HCM
77
Highbridge Capital Management
New York
– -$99K -3,429 Closed
GT
78
Glenmede Trust
Pennsylvania
– -$10K -375 Closed
1 2 3
4